Announcement: SignalChem has changed its corporate name from “SignalChem Pharmaceutical Inc.” to “SignalChem Biotech Inc.” effective March 20th, 2019.

Isoform Specific Antibodies

SignalChem offers highly validated paralog specific enzymes that specifically recognize the intended target with high affinity. All of these antibodies are counter-screened in-house against sets of closely related proteins to ensure specificity.